Harmony Biosciences Holdings, Inc. (HRMY) shares soared 8.3% in the last trading session to close at $33.36. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock’s 30.1% loss over the past four weeks.
The sudden soaring of the stock price is likely due to the positive momentum built around Harmony’s announcement on Wednesday. The company now expects to complete enrollment in the phase III INTUNE study of pitolisant, in the second quarter of 2023. In the study, pitolisant’s safety and efficacy is being evaluated for the treatment of idiopathic hypersomnia in adults. Topline data from the study is anticipated in the fourth quarter of 2023.
This company is expected to post quarterly earnings of $0.44 per share in its upcoming report, which represents a year-over-year change of -13.7%. Revenues are expected to be $118.21 million, up 38.6% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Harmony Biosciences Holdings, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock’s price usually doesn’t keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on HRMY going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>
Harmony Biosciences Holdings, Inc. belongs to the Zacks Medical – Biomedical and Genetics industry. Another stock from the same industry, 2seventy bio, Inc. (TSVT), closed the last trading session 8.4% higher at $9.98. Over the past month, TSVT has returned -31.7%.
For 2seventy bio, Inc.
Is THIS the Ultimate New Clean Energy Source? (4 Ways to Profit)
The world is increasingly focused on eliminating fossil fuels and ramping up use of renewable, clean energy sources. Hydrogen fuel cells, powered by the most abundant substance in the universe, could provide an unlimited amount of ultra-clean energy for multiple industries.
Our urgent special report reveals 4 hydrogen stocks primed for big gains – plus our other top clean energy stocks.
See Stocks Now
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Harmony Biosciences Holdings, Inc. (HRMY) : Free Stock Analysis Report
2seventy bio, Inc. (TSVT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
